Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alzamend Neuro, Inc. Director's Dealing 2021

Aug 20, 2021

35321_dirs_2021-08-19_d433014a-9445-4b6a-b4d3-5807a9c45e6c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alzamend Neuro, Inc. (ALZN)
CIK: 0001677077
Period of Report: 2021-08-17

Reporting Person: AULT MILTON C III (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-17 Common Stock P 4000 $3.2925 Acquired 6709388 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 15000000 Indirect
Common Stock 10000000 Indirect

Footnotes

F1: The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $3.2925. The range of purchase prices on the transaction date was $3.23 to $3.35 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.

F2: Digital Power Lending, LLC ("DPL") is a wholly-owned subsidiary of Ault Global Holdings, Inc. ("AGH"). Mr. Ault, the Executive Chairman of AGH, is deemed to have voting and investment power with respect to the securities held of record by DPL.

F3: Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.

F4: Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.